Gilead Sciences Eulerpool News

Gilead Sciences Eulerpool News

Gilead Sciences Notizie Azioni

Gilead Sciences è seguito da molti giornalisti e investitori in tutto il mondo. Qui raccogliamo le più recenti notizie Gilead Sciences.

• 4 ottobre ·

  Benzinga
  Peeling Back The Layers: Exploring Gilead Sciences Through Analyst Insights
• 3 ottobre ·

  Yahoo
  Gilead signs agreements to facilitate access to HIV prevention drug
• 2 ottobre ·

  Yahoo
  Hetero Signs Voluntary Licensing Agreement with Gilead to Transform Global HIV response, Expanding Access to Groundbreaking Lenacapavir to 120 high-incidence countries
• 2 ottobre ·

  Yahoo
  Gilead Signs Royalty-Free Voluntary Licensing Agreements With Six Generic Manufacturers to Increase Access to Lenacapavir for HIV Prevention in High-Incidence, Resource-Limited Countries
• 2 ottobre ·

  Thefly.com
  Dr. Reddy's signs licensing agreement with Gilead for lenacapavir in India
• 2 ottobre ·

  Thefly.com
  Hetero signs licensing agreement with Gilead expanding access to Lenacapavir
• 2 ottobre ·

  Seeking Alpha
  Gilead signs deals with six drugmakers for generic lenacapavir
• 2 ottobre ·

  Thefly.com
  Gilead in royalty-free generic manufacturing deals for lenacapavir for HIV
• 1 ottobre ·

  SeekingAlpha
  Gilead Sciences: My Worst Stock Move In 2024, And What I Learned From It
• 28 settembre ·

  Seeking Alpha
  Here are the Medicare Part D drugs expected to face 2025 price negotiations